Nutrition
Volume 26, Issue 3 , Pages 255-262 , March 2010

Breast cancer survivors and vitamin D: A review

  • Stephanie L. Hines, M.D.

      Affiliations

    • Division of Consultative and Diagnostic Medicine, Mayo Clinic, Jacksonville, Florida, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-507-284-8917; fax: +1-507-284-2107.
    • ,
  • H. Keels S. Jorn, M.D.

      Affiliations

    • Division of Community Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA
    • ,
  • Kristine M. Thompson, M.D.

      Affiliations

    • Department of Emergency Medicine, Mayo Clinic, Jacksonville, Florida, USA
    • ,
  • Jan M. Larson, M.D.

      Affiliations

    • Department of Family Medicine, Mayo Clinic, Jacksonville, Florida, USA

Received 21 May 2009 ,Accepted 17 August 2009.

References 

  1. In:  Hewitt M,  Greenfield S,  Stovall E editor. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006;
  2. Vitamin D. ChemIDPlus advanced. Bethesda, MD: National Library of Medicine; 2008;
  3. Dial J, Sandoval M, Reid S, Vitamin D. Micromedex Healthcare Series. Colorado: Thomson Reuters (Healthcare) Inc.; 2000;
  4. Kemmis CM, Welsh J. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem. 2008;105:980–988
  5. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1 α-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol. 2005;97:103–109
  6. Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, et al. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res. 2005;11:3579–3586
  7. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990;19:820–824
  8. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990;19:614–622
  9. Gorham ED, Garland CF, Garland FC. Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health. 1989;80:96–100
  10. John EM, Schwartz GG, Dreon DM, Koo J. National Health and Nutrition Examination Survey. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. Cancer Epidemiol Biomarkers Prev. 1999;8:399–406
  11. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1991–1997
  12. Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev. 2006;15:1427–1437
  13. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case–control study. Cancer Epidemiol Biomarkers Prev. 2007;16:422–429
  14. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med. 2007;28:1050–1059
  15. McCullough ML, Rodriguez C, Diver WR, Feigelson HS, Stevens VL, Thun MJ, et al. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2005;14:2898–2904
  16. Garland CF, Grant WB, Mohr SB, Gorham ED, Garland FC. What is the dose–response relationship between vitamin D and cancer risk?. Nutr Rev. 2007;65(8 pt 2):S91–S95
  17. Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103:708–711
  18. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, et al. Women's Health Initiative Investigators Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100:1581–1591
  19. Speers C, Brown P. Breast cancer prevention using calcium and vitamin D: a bright future?. J Natl Cancer Inst. 2008;100:1562–1564
  20. Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008;88:133–139
  21. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In:  Kronenberg HM,  Melmed S,  Polonsky KS,  Larsen PR editor. Williams textbook of endocrinology. 11th ed. Philadelphia: Saunders Elsevier; 2008;p. 1203–1268
  22. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281
  23. Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer. 2008;122:461–467
  24. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989;1:188–191
  25. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C, et al. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation. 2007;75:193–207
  26. Roy D, Calaf G, Hei TK. Role of vitamin D receptor gene in radiation-induced neoplastic transformation of human breast epithelial cell. Steroids. 2003;68:621–627
  27. Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S. South-East Sweden Breast Cancer Group. Association of breast cancer progression with a vitamin D receptor gene polymorphism. Cancer Res. 1999;59:2332–2334
  28. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotypes and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41:1164–1169
  29. El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, Goltzman D, et al. The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res. 2000;60:4412–4418
  30. VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology. 1998;139:2102–2110
  31. Palmieri C, MacGregor T, Girgis S, Vigushin D. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol. 2006;59:1334–1336
  32. Porojnicu AC, Lagunova Z, Robsahm TE, Berg JP, Dahlback A, Moan J. Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat. 2007;102:323–328
  33. Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004;15:149–158
  34. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705–712
  35. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49–56
  36. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28(errata Am J Clin Nutr 2006;84:1253 and 2007;86:809)
  37. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Sierra A, et al. High prevalence of vitamin D deficiency in a multi-ethnic cohort of premenopausal breast cancer patients. J Clin Oncol. 2008;26(15S):abstract 9583
  38. Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer. 1999;79:1179–1181
  39. Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE ATAC Trialists' Group. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). J Bone Miner Res. 2006;21:1215–1223
  40. Perez EA, Weilbaecher K. Aromatase inhibitors and bone loss. Oncology (Williston Park). 2006;20:1029–1039
  41. Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol. 1996;14:78–84
  42. Lonning PE, Geisler J, Krag E, Lokkevik E, Risberg T, Hagen AI, et al. Vitamin D deficiency: a threat to bone health in breast cancer patients during adjuvant treatment with aromatase inhibitors. J Clin Oncol. 2006;24(18S):abstract 554
  43. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149:242–250
  44. Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa S, O'dea AP, et al. Effect of high-dose vitamin D on joint pain and fatigue from adjuvant letrozole. J Clin Oncol. 2008;26(15S):abstract 9618
  45. Simmons C, Ooi W, Dranitsaris G, Cole DE, Vieth R, Oldfield M, et al. Phase II study of vitamin D (10,000 IU daily) supplementation in bisphosphonate-treated breast cancer patients with bone metastases (abstract 176). Presented at the 2008 Breast Cancer Symposium; Washington, DC; September 5–7, 2008.
  46. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65:508–512
  47. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008;11:7–12
  48. Hampton T. Breast cancer prevention strategies explored. JAMA. 2006;295:2128–2129
  49. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353–373
  50. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68:854–858
  51. Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92:2130–2135
  52. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005;10:94–111
  53. US Department of Agriculture. Nutrient database. Available at: http://www.nal.usda.gov/fnic/foodcomp/search/. Accessed July 18 2009.
  54. Vitamin D deficiency: a new understanding. Mayo Clin Endocrinol Update. 2006;1:4–5
  55. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Vitamin D: DRI dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academies Press; 1997;p. 250–87
  56. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85:649–650
  57. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002;112:659–662
  58. Institute of Medicine. Available at: http://www.iom.edu/?ID=61770. Accessed July 18, 2009.
  59. Vitamin D. HazardText. Thomson Healthcare; 2008. Available at: http://www.thomsonhc.com/hcs/librarian/ND_T/HCS/ND_PR/Main/CS/F13564/DUPLICATIONSHIELDSYNC/4F8418/ND_PG/PRIH/ND_B/HCS/SBK/2/ND_P/Main/PFPUI/U41ex6J2SRDVeI/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/46/ContentSetId/54/SearchTerm/vitamin/SearchOption/BeginWith. Accessed October 12, 2008.
  60. Vitamin D. Poisindex managements. Thomson Healthcare; 2008. Available at: http://www.thomsonhc.com/hcs/librarian/ND_T/HCS/ND_PR/Main/CS/F13564/DUPLICATIONSHIELDSYNC/4F8418/ND_PG/PRIH/ND_B/HCS/SBK/5/ND_P/Main/PFPUI/U41ex6J2SRErId/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/46/ContentSetId/51/SearchTerm/vitamin%20d%20/SearchOption/BeginWith. Accessed October 12, 2008.

 Dr. Hines received research grants from Novartis, Sanofi-Aventis, and AstraZeneca for research in bone studies in patients with breast cancer using bisphosphonates (no relation to the present study).

PII: S0899-9007(09)00362-1

doi: 10.1016/j.nut.2009.08.020

Nutrition
Volume 26, Issue 3 , Pages 255-262 , March 2010

Article Tools

* Image Usage & Resolution